NGL Fine-Chem (BOM:524774) Change In Payables And Accrued Expense : ₹0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is NGL Fine-Chem Change In Payables And Accrued Expense?

NGL Fine-Chem's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ₹0 Mil. It means NGL Fine-Chem's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

NGL Fine-Chem's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was ₹0 Mil. It means NGL Fine-Chem's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .

NGL Fine-Chem Change In Payables And Accrued Expense Historical Data

The historical data trend for NGL Fine-Chem's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NGL Fine-Chem Change In Payables And Accrued Expense Chart

NGL Fine-Chem Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

NGL Fine-Chem Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

NGL Fine-Chem Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

NGL Fine-Chem Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of NGL Fine-Chem's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

NGL Fine-Chem (BOM:524774) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NGL Fine-Chem Ltd (BOM:524774) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

NGLFINE:India

Address

301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057

Website

https://www.nglfinechem.com

NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. The company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Its product includes Active Pharmaceutical Ingredients (APIs) animal health, APIs human health, Intermediates and Finished dosage form, of which maximum revenue is generated from Veterinary APIs. Its geographical segments include India, Europe, Asia Pacific, United States, and Rest of the world. The Group's business activities fall within a single business segment of pharmaceuticals.

NGL Fine-Chem (BOM:524774) Headlines

No Headlines